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Abstract
Background: In areas with limited structure in place for microscopy diagnosis, rapid diagnostic tests (RDT) have
been demonstrated to be effective.
Method: The cost-effectiveness of the Optimal® and thick smear microscopy was estimated and compared. Data
were collected on remote areas of 12 municipalities in the Brazilian Amazon. Data sources included the National
Malaria Control Programme of the Ministry of Health, the National Healthcare System reimbursement table,
hospitalization records, primary data collected from the municipalities, and scientific literature. The perspective was
that of the Brazilian public health system, the analytical horizon was from the start of fever until the diagnostic
results provided to patient and the temporal reference was that of year 2006. The results were expressed in costs
per adequately diagnosed cases in 2006 U.S. dollars. Sensitivity analysis was performed considering key model
parameters.
Results: In the case base scenario, considering 92% and 95% sensitivity for thick smear microscopy to Plasmodium
falciparum and Plasmodium vivax, respectively, and 100% specificity for both species, thick smear microscopy is
more costly and more effective, with an incremental cost estimated at US$549.9 per adequately diagnosed case. In
sensitivity analysis, when sensitivity and specificity of microscopy for P. vivax were 0.90 and 0.98, respectively, and
when its sensitivity for P. falciparum was 0.83, the RDT was more cost-effective than microscopy.
Conclusion: Microscopy is more cost-effective than OptiMal® in these remote areas if high accuracy of microscopy
is maintained in the field. Decision regarding use of rapid tests for diagnosis of malaria in these areas depends on
current microscopy accuracy in the field.
Background
In Brazil, 99.8% of malaria cases occur in the Amazon
Region, of which more than 70% are due to Plasmodium
vivax [1]. Risk for malaria is given by the malaria annual
parasitic incidence (API) which stratifies in high (> 49.9
malaria cases/1,000 population), medium (10 - 49.9
cases/1,000 population) or low (< 10 cases/1,000 popula-
tion) risk [2,3]. Between 2003 and 2007, the API of the
Amazon Region ranged from 18.3 to 26.6 cases/1,000
population. In 2007, 457,659 cases were registered in
the region, with an API of 19.2 cases/1,000 population
[1].
Early and accurate diagnosis is crucial as it enables the
institution of prompt and adequate treatment, minimiz-
ing the risk of complications, the duration of disease
and therefore its medical and economic burden. Reliable
and efficient diagnostic methods are therefore essential
in endemic countries [4].
Microscopy with the thick smear method is the most
common method for malaria diagnosis. It is of low cost
[5], and allows direct visualization of the parasite, there-
fore, identifying all of the Plasmodium species and
quantifying parasites in the blood. Its execution requires
well-maintained laboratories, and experienced and
highly trained professionals. The technique has its inher-
ent limitations, such as variability in the quality of the
blood smear, inability to determine the parasite species
when parasitaemia is very low and loss of slide quality
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slides may vary among technicians [5-8].
In Brazil, microscopic diagnosis is available in most of
the areas with endemic malaria transmission. In the
Amazon Region, there are 3,240 active microscopy
laboratories (data from January 2008) distributed in all
nine states of the Region [9]. However, limitations for
diagnosis in some areas persist, which are associated
with difficulty in access to services, population mobility
and high cost of microscopy in remote locations [10].
In the 1990 s, rapid immunochromatographic diagnos-
tic tests (RDT) were developed. RDT detects specific
Plasmodium antigens in blood collected from a finger
stick. Diagnosis using RDT can be completed in 15 min-
utes by individuals with minimal training, and its use do
not require electricity or any specialized equipment [11].
It offers a useful alternative particularly in remote loca-
tions where it is difficult to establish and maintain
microscopy laboratories. Disadvantages of the RDT
include the inability to identify mixed Plasmodium
infections, to differentiate between the various Plasmo-
dium species, and its high cost [11].
Despite its costs, in areas with limited structure in
place for microscopy diagnosis, RDT has been demon-
s t r a t e dt ob ee f f e c t i v e[ 1 1 ]a n di t su s eh a sb e e nr e c o m -
mended by the WHO for endemic remote areas with
difficult access [11].
Various studies have reported the high accuracy of the
OptiMAL® RDT in Brazil, Colombia, Africa and Asia
[12-16]. In Brazil, the National Malaria Control Pro-
gramme of the Brazilian Ministry of Health recommends
RDT use in no endemic areas or in areas of difficult
access [17], as laboratory structure for microscopy is not
always available in these areas. However, evaluation of
costs and cost-effectiveness of its use has not been yet
conducted.
The aims of this study were to estimate the total cost
of diagnosis of new malaria cases and the cost-effective-
ness ratio of using OptiMAL® RDT compared to con-
ventional thick smear microscopy for malaria diagnosis
in remote areas of the Amazon Region. This will provide
important information to assist national decision makers
on the impact of RDT and to formulate public health
policies regarding the use of RDT for malaria diagnosis
in such areas.
Methods
Decision analytic model
A decision tree was developed to compare the use of
OptiMAL® RDT to the conventional thick smear micro-
scopy as diagnostic strategies for malaria in remote
endemic areas (Figure 1).
A hypothetical cohort of all individuals with fever who
had a diagnostic procedure for malaria conducted in
2006 (n = 33,491) was simulated considering its various
probability nodes. All individuals (100%) presenting with
fever to health facilities would undergo diagnostic test
using either microscopy or RDT. They could either have
malaria or not (prevalence of malaria in the population).
If this patient had malaria, the diagnostic test could result
positive for malaria (sensitivity) - indicating infection due
to Plasmodium falciparum or P. vivax -r e p r e s e n t i n ga
true positive result; or result negative (1-sensitivity)
representing a false negative result. If this patient did not
have malaria, the diagnostic test could result negative
(specificity) representing a true negative result; or result
positive (1-specificity) representing a false positive result.
While true positive and true negative results were consid-
ered as adequately diagnosed cases, false negatives and
false positives were considered as incorrectly diagnoses
cases. These were the terminal nodes of the decision tree
(Figure 1). Cost data and epidemiological were collected
and inputted to populate this decision tree.
Study area
Data was collected from remote areas in 12 municipali-
ties in the state of Pará in the Amazon Region, where
malaria is endemic. In these municipalities, approxi-
mately 30% of febrile cases tested for malaria each year
live in areas where no laboratory facility for microscopy
diagnosis is available. Risk of malaria considering API in
the municipalities varied from 6.28 to 184.27 cases/per
1,000 population in 2006.
In 2006, these municipalities introduced Optimal®
RDT for varying periods of time. Thus, some primary
data from areas using OptiMAL® RDT was available and
collected for this analysis.
In remote areas, malaria diagnosis requires health-
care workers to actively seek out febrile patients and
collect their blood. Microscopy diagnosis rely blood
collection during the first patient encounter and trans-
portation of this sample to the nearest laboratory
where trained technicians can perform diagnosis.
Healthcare workers then need to return to the areas to
provide the diagnosis to the patient, and therapy for
malaria cases is instituted at that time. RDT diagnosis
is done on site during the first encounter of healthcare
workers with the febrile patient, when finger stick
blood is collected. Therapy for malaria positive cases is
delivered on site during this same visit as diagnostic
results are readily available.
This cost effectiveness analysis took into consideration
the above description of provision of diagnosis and care
for febrile cases in the area studied. A hypothetical
cohort of cases was followed up from fever onset to
diagnostic results provided (analytical framework). The
study period was January-December 2006. The analysis
perspective was that of the Brazilian Public Health
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adequately diagnosed cases of malaria.
Costs of malaria diagnosis
Direct medical and non-medical costs were considered.
All costs were calculated in Brazilian Reais and con-
verted to U.S dollars considering the official average
exchange rate for 2006 (US$1.00 = R$2.17) [18].
Costs data was obtained from various sources. Primary
data sources was collected at the Municipal and State
Health Departments of Novo Repartimento municipality
and the state of Pará. Secondary data sources included
the scientific literature, official government reports,
manuals, and administrative acts from the Malaria Con-
trol Programme, the National Strategic Inputs System
(SIES), the reimbursement table for procedures by the
National Health System (SUS) and the SUS Hospital
Information System [19-23].
Costs considered for microscopy diagnostic strategy
included: thick smear microscopy with consumables and
supplies, equipment costs (microscope purchase and
maintenance), transportation for sample collection and
delivery of results, and training for healthcare profes-
sionals performing thick smear microscopy.
Costs considered for OptiMal® diagnostic strategy
included consumables and supplies (gloves and
Figure 1 Decision tree for the “adequately diagnosed cases”. Notes: RT - Rapid Test; Neg - negative; + - positive;/1 - adequately diagnosed
case;/0 - inadequate diagnosis
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delivery of results, and training for healthcare profes-
sionals performing rapid tests.
Thick smear microscopy and OptiMal® RDT costs
Consumables and supply costs for microscopy were aggre-
gated into one estimated cost measure of conducting a sin-
gle thick smear procedure. In the base case, cost of one
thick smear procedure was the one estimated by Macauley
in Brazil [24] based on costs of all used microscopy sup-
plies through a passive case detection diagnosis strategy.
Upper level variation for sensitivity analysis also consid-
ered Macauley [24] estimates through a passive plus active
case detection diagnosis strategy. As these costs were esti-
mated for 2001, they were adjusted for inflation consider-
ing Index Consumers Price [25]. Lower level variations
around the base-case were estimated for sensitivity analysis
using micro-costing techniques in which the cost of indivi-
dual consumables required to perform one thick smear
procedure were estimated. Primary cost data was obtained
from the Malaria Laboratory of the Evandro Chagas Insti-
tute of the Brazilian Health Ministry (personal communi-
cation). The cost of purchase of the OptiMal® RDT was
obtained from the Brazilian Health Ministry [19].
Equipment costs
The cost of purchase of the microscope was obtained
from the Brazilian Health Ministry. It was assumed that
t h e r ew a so n em i c r o s c o p ea v a i l a b l ef o ru s ef o re v e r y
professional and an annual maintenance for each equip-
ment. The cost of the microscope was averaged over the
year based on a discount rate of 5% and an average life
of 15 years [26,27].
Transportation costs
Transportation costs considered for the microscopy
diagnostic strategy included two trips of one healthcare
professional into the remote area; one for specimen col-
lection and a second one for delivery of results. Trans-
portation costs considered for the RDT considered one
trip of one healthcare professional into the remote area
for both collection of sample and delivery of results.
Transportation costs to remote areas were estimated
considering data provided by municipal level on the use
of fuel (personal communication). The prices of gasoline
and diesel for 2006 were collected from the official Bra-
zilian government website [28,29].
Training costs
Training costs considered one annual 40-hour training
for the thick smear microscopy procedure and one
annual 150 minutes training for the RDT [30]. The esti-
mated cost was obtained from the Brazilian Health Min-
istry considering the microscopy training held in 2006.
Costs of equipment, transportation, and salary staff
which are shared with other health programs were esti-
mated considering WHO’s parameters which determine
the number of microscopy diagnostic tests performed per
hour at four different levels of malaria prevalence [31].
Thus, the study area was stratified according to API into
four prevalence categories and the number of healthcare
professionals needed to conduct the diagnostic proce-
dures was estimated. Costs of equipment, transportation,
and salary staff where then estimated, assuming them to
be directly proportional to the number of healthcare pro-
fessionals needed to conduct the diagnostic procedures.
The total for each diagnostic strategy for these items
represented the average costs in the study area weighted
by prevalence in each risk strata.
Costs of quality control procedures for microscopy
and RDT diagnostic methods and costs of construction
and maintenance of laboratories were not considered.
Table 1 presents cost components and their respective
unit costs for microscopy and OptiMal® RDT diagnosis.
Epidemiological parameters
Secondary sources of epidemi o l o g i cd a t aw e r ec o n s i d -
ered and obtained from the scientific literature (medline,
Lilacs and SciElo databases), and the National Malaria
Surveillance Information System of Health Ministry [9].
These data included prevalence of malaria, proportion
o fm a l a r i ac a s e sd u et oP. vivax and P. falciparum spe-
cies, sensitivity and specificity of microscopy and Opti-
Mal® RDT for both P. vivax and P. falciparum infections
(Table 2).
Accuracy studies for OptiMAL® RDT were considered
only if they used microscopy as the gold standard in
endemic areas. Quality of published studies was assessed
considering 14 criteria of the Quality Assessment of
Diagnostic Accuracy Studies (QUADAS) instrument [32]
and three additional criteria judged relevant: socio-
demographic characteristics of patients, confidence
i n t e r v a la n dt h es a m p l i n gm e t h o da sp r o p o s e db yt h e
Standards for Reporting Studies of Diagnostic Accuracy
(STARD) [33]. From 30 studies, only 14 fulfilled mini-
mum quality criteria. From these, five studies were
deemed as being of better quality considering the above
criteria [7,12-15]. These were the sources of the sensitiv-
ity and specificity values in the case base and variation
considered in sensitivity analysis. Accuracy studies of
thick smear microscopy were considered only if they
used polymerase chain reaction as the gold standard
[6,16,34-36].
Cost, cost-effectiveness and sensitivity analysis
TreeAge Pro® software was used to build the decision
model and for cost-effectiveness and sensitivity analyses
[37]. Total costs accrued for malaria diagnosis during
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strategies considering the total number of exams per-
formed during the study period (n = 33,491). Cost per
adequate diagnosis was obtained for both microscopy
and OptiMAL® RDT diagnostic methods by dividing
total costs by the estimated number of cases diagnosed.
The cost-effectiveness decision model predicts the
number of adequate diagnosis of febrile patients with
suspected malaria and costs associated with each diagno-
sis. Incremental cost-effectiveness ratio (ICER) was calcu-
lated considering the incremental cost needed to
adequately diagnose one individual with suspected
malaria using OptiMAL® RDT as opposed to microscopy.
In order to examine the variability of the cost-effec-
tiveness ratios, one-way sensitivity analysis to investigate
the effect of key parameter values was conducted. Cost
parameters for microscopy and RDT diagnosis (exams
and supplies, equipment, transportation and training)
were varied, as were also malaria prevalence and accu-
racy estimates for both diagnostic methods. Parameter
values varied over the upper and lower range estimates.
Variation of costs (Table 1) and epidemiologic para-
meters (Table 2) considered in the analysis and their
respective sources of information are presented.
Results
Considering 33,491 diagnostic procedures for malaria
conducted in 2006, the total cost of the microscopy
strategy would be US$227,315.53, and for the OptiMal®
RDT, US$172,082.09 (Table 3). The cost per adequately
diagnosed case was US$ 5.14 using OptiMal® RDT and
US$ 6.79 using microscopy (Table 4).
Considering the total 33,491 tests performed, micro-
scopy and RDT adequately diagnosed 32,989 and 32,888
cases, respectively. In the base-case scenario, RDT was
less effective failing to diagnose 3 cases in 1,000 febrile
patients comparing to microscopy. Thus, incremental
cost-effectiveness ratio was US$ 549.92 per adequately
diagnosed case for microscopy when compared to Opti-
Mal® RDT (Table 4). Results are presented in reverse, to
avoid negative values, so actually is presented CE ratios
of microscopy compared to RDT.
Table 1 Cost components and unit costs considered for malaria diagnosis, Amazon Region, Brazil in 2006
Items Unit cost considered in the
base-case
analysis and variation
(US$)
Information sources
Exams and supplies
Thick smear - one exam
(1) 0.92 (0.19-1.40) Base-case: Macauley, 2005
Variation: Malaria Lab of Evandro Chagas Institute; Macauley,2005
OptiMal® - one test 4.28 (3.59 Base-case: Union Official Gazette, 2006
- 4.93) Variation: DiaMed Laboratory; State of Pará
Gloves to use with RDT 0.02 (0.05) Base-case and variation: Stock Prices of Ministry of Health
Salaries
Microscope technician - monthly salary 290.93 Base-case: Health care center/Municipality Novo Repartimento
Health worker - monthly salary 214.38 Base-case: Health care center/Municipality Novo Repartimento
Equipment
Microscope - one unit - annual value 485.65 (327.94) Base-case and variation: Ministry of Health
Microscope maintenance - one annual
maintenance
36.87 Base-case: Malaria Lab of Evandro Chagas Institute
Transportation
For the rapid test - average monthly cost 1,450.23 (855.30 - 16,428.14) Base-case Health care center/Municipality Novo Repartimento
For microscopy - average monthly cost 2,900.46 (1,710.60 - 32,856.28) Base-case and variation: Health care center/Municipality Novo
Repartimento
Training
Microscopy - one annual course per
municipality
11,137.79 (5,934.34) Base-case and variation: Ministry of Health
Rapid test - one annual course per
municipality
116.02 (61.82) Base-case and variation: Ministry of Health
Notes:
Corresponds to the individual cost of an examination, which includes a glass slide, Giemsa and other stains (all components of stains), oil immersion, lancet,
cotton, alcohol, and gloves.
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In sensitivity analysis, cost-effectiveness ratios were sen-
sitive to some parameters (Table 5). The largest impact
on results were observed when sensitivity of microscopy
for both Plasmodium species was lower than base-case,
resulting in microscopy being both more costly and less
effective and therefore dominated by the RDT strategy.
This was observed when microscopy sensitivity for P.
vivax was 0.90 or lower, sensitivity for P. falciparum
0.83 or lower, and microscopy specificity for P. vivax
was 0.98 or lower.
When specificity of OptiMal® RDT was lower, cost-
effectiveness ratio changed proportionately, with an
incremental cost-effectiveness varying from US$ 15.86
Table 2 Epidemiologic parameters considered in the analytic model, Amazon Region, Brazil, 2006
PARÂMETER BASE-
CASE
VALUE
VARIATION
VALUES
INFORMATION
SOURCES*
Prevalence of malaria among febrile patients seeking
diagnosis
(1)
24.6% 12.7% - 28.5% Base-case and variation: SIVEP/Malaria
Proportion of malaria cases due to Plasmodium vivax
(1)
67.2% 63.6% - 92.4% Base-case and variation: SIVEP/Malaria
Proportion of malaria cases due to Plasmodium
falciparum
(1)
32.8% 7.6% - 36.4% Base-case and variation: SIVEP/Malaria
Sensitivity of microscopy for Plasmodium vivax 95% 77% - 82% Base-case: Ohrt et al., 2002
Variation: Haghdoost et al.,2006; Iqbal et al., 1999
Specificity of microscopy for Plasmodium vivax 100% 95.0% -100.0% Base-case: Haghdoost et al.,2006
Variation: Haghdoost et al.,2006
Sensitivity of microscopy for Plasmodium falciparum 92% 83% - 92% Base-case: Ohrt et al., 2002
Variation: Humar et al., 1997
Specificity of microscopy for Plasmodium falciparum 100% 99% - 100% Base-case: Ndao et al., 2004
variation: Humar et al., 1997
Sensitivity of OptiMal® for Plasmodium vivax 92% 62.5% -100% Base-case: PAHO Report, elaborated by Fontes, 2002
Variation: Ratsimbasoa et al.,2007; Londoño et al., 2002
Specificity of OptiMal® for Plasmodium vivax 100% 80% - 100% Base-case: PAHO Report, elaborated by Fontes, 2002
Variation: Londoño et al., 2002
Sensitivity of OptiMal® for Plasmodium falciparum 95.6% 62.3% - 98.8% Base-case: PAHO Report, elaborated by Fontes, 2002
Variation: Palmer et al., 1998; OPAS Report, elaborated by
Fontes, 2002
Specificity of OptiMal® for Plasmodium falciparum 99.6% 89.3% - 100% Base-case: PAHO Report, elaborated by Fontes, 2002
Variation: Ferro et al.,2002; Ratsimbasoa et al.,2007
Notes: * To the “Variation values”, the first citation refers to the lowest value,
and the second citation refers to the highest value.
(1) The base-case values correspond to the values aggregated from 12 municipalities, and variation values correspond to the lowest and highest values found in
the different risk strata presented in the 12 municipalities.
Table 3 Total costs of diagnostic strategies for 33,491 exams performed in the study area, Amazon Region, Brazil,
2006
Items Microscopy strategy
(US$)
RDT strategy
(US$)
Thick smear microscopy 30,712.94 –
OptiMal® rapid test – 143,224.18
Latex gloves to use with RDT – 771.68
Salary of technician to read smear using microscopy 23,826.86 –
Salary of health workers 17,557.55 17,557.55
Microscopes 3,059.56 –
Maintenance of microscopes 232.26 –
Transportation 18,272.90 9,136.45
Training 133,653.46 1,392.22
Cost of diagnosis 227,315.53 172,082.09
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microscopy. When higher transportation costs to per-
form RDT were assumed, RDT was dominated by
microscopy. Changes in the other parameters did not
result in changes in the cost-effectiveness ratios.
Discussion
Although OptiMal® RDT is more expensive than thick
smear when only the procedure costs are considered,
this study demonstrated that when all cost components
of malaria diagnosis are considered - personnel, equip-
ment, maintenance, training and transportation - micro-
scopy is more costly than OptiMal® RDT. In remote
areas, routine malaria diagnosis requires active case
search by community health agents, and at least two
trips in order to collect specimens and provide diag-
noses to suspected cases.
Microscopy strategy was more effective and more
cost-effective than OptiMal® in remote endemic areas
when high sensitivity (92-95%) and specificity (100%)
were maintained.
The model was sensitive to small variations of speci-
men-specific sensitivity and specificity of microscopy for
malaria diagnosis. When sensitivity and specificity of
microscopy for P. vivax were 0.90 and 0.98, respectively,
and when its sensitivity for P. falciparum was 0.83,
OptiMal® RDT was more cost-effective than microscopy,
indicating that very high microscopy accuracy levels are
needed for microscopy to be more cost-effective than
R D T .U n l i k en e w l ya v a i l a b l et e c h n o l o g i e s ,w h e nt h e
price of one RDT OptiMal® test was reduced, results did
not vary significantly.
Lubell et al [38], Shillcutt et al [39], Rolland et al [40],
and Chanda et al [41] prompted the need for alternative
malaria diagnostic methods in studies conducted in Africa,
where low accuracy of diagnosis was observed. In countries
where presumptive malaria treatment considering clinical
signs and symptoms is recommended, specificity of diag-
nosis strategy is close to zero, and the use of RDT for
malaria diagnosis was demonstrated to be very cost-effec-
tive when compared to standard practice as this would
avoid presumptive treatment of false positive cases [39,40].
Lubell et al [38] and Chanda et al [41] demonstrated that
RDT was cost effective when compared to microscopy also
in settings where microscopy accuracy was low.
Only one published study was conducted in the Ama-
zon Region, which is endemic for malaria [42]. It was
demonstrated that in remote areas RDT led to cost-sav-
ings for outcomes considered - timely and appropriate
treatment, serious malaria cases and deaths averted -
when compared to microscopy. However, this study did
not consider diagnostic method accuracy as parameters
in the model, and therefore it is difficult to compare
these results. A cost-minimization analysis conducted in
a rural locality in Brazil demonstrated that the RDT
ParaSight-F® was more cost effective than microscopy,
mainly due to significantly lower transportation costs
when using RDT [43].
This study demonstrated that microscopy was cost-
effective when compared to OptiMal® when high accu-
racy of thick smear technique was maintained.
True accuracy of microscopy diagnostic techniques in
the field is unknown in most endemic countries. This is
due to difficulties in establishing adequate gold standard
against which to determine sensitivity and specificity of
microscopy.
In the Brazilian Amazon Region, the infra-structure
for microscopy diagnosis is in place in most areas and,
Table 4 Results of the cost-effectiveness analysis of the
microscopy compared to OptiMal® , Amazon Region,
Brazil, 2006
Strategy Cost per
case
(US$)
Additional
cost
(US$)
Effect Additional
effect
ICER
(US$)
OptiMal® 5.14 0.982
Microscopy 6.79 1.65 0.985 0.003 549.92
Table 5 Results of the sensitivity analysis, Amazon
Region, Brazil, 2006
Parameter and variation value * Incremental cost-
effectiveness ratio
(ICER) (US$)
Microscopy sensitivity for P. vivax
0.90 Microscopy dominated
Microscopy specificity for P. vivax
0.98 Microscopy dominated
Microscopy sensitivity for P. falciparum
0.90 1,649.77
0.83
Microscopy dominated
Specificity of OptiMal® kit for P. vivax
0.95 58.92
0.80 15.86
Cost of OptiMal®
4.93 333.33
3.59 778.80
Cost of transportation to perform one
rapid test
3.08 Rapid test dominated
0.16 586.79
Cost of transportation to perform one
thick smear
6.18 2,428.57
2.12 Rapid test dominated
Cost-effectiveness analysis of the microscopy compared to OptiMal®.
Note: * Only variation values in which changes in ICER occurred are
presented.
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of setting up this structure, which is known to be costly.
If considered, microscopy costs would be higher. There-
fore, RDT use may be the best available diagnostic alter-
native in remote endemic areas where infra-structure
for microscopy diagnosis is not in place, or where high
accuracy of microscopy cannot be assured.
The model was also sensitive to variations in OptiMal®
specificity to P. vivax, leading to lower cost per each
additional diagnosed case for microscopy when Opti-
Mal® specificity was lower. Although various different
RDTs are available, they differ significantly in sensitivity
and specificity values. When making informed decisions
on RDT introduction, a product with high accuracy
should be selected, as recommended by the WHO [11].
Finally, further developments on determining gold
standards and processes to evaluate sensitivity and spe-
cificity of microscopy diagnostic procedure for malaria
are urgently needed. Decision making on the use of the
microscopy or RDT as alternative diagnostic procedure
in remote endemic areas considering cost-effectiveness
is strongly dependent upon knowledge of true accuracy
of microsocopy in the field.
Conclusion
Microscopy is more cost-effective than OptiMal® in
these remote areas if high accuracy of microscopy is
maintained in the field. Decision regarding use of rapid
tests for diagnosis of malaria in these areas depends on
current microscopy accuracy in the field.
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